Your web browser doesn’t have the Flash Player v.9 plugin installed, so this Website can’t be properly viewed.
For full experience, please download the latest Flash plugin at Adobe.com.
Download Adobe Flash Player now.
Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) Recombinant Vaccine
While many private health plans are providing coverage for GARDASIL®, levels of coverage can vary. Your coverage can even change over time. Because your healthcare professional has many patients with different health insurance benefits, he or she may not know your specific level of coverage for GARDASIL®. Before you visit the healthcare professional’s office, you may want to call your health plan to find out more about your level of coverage.
By contacting your health plan directly, you can get the most accurate information about your plan’s coverage for GARDASIL®.
Call the phone number on your medical benefit card to learn whether any co-pays, co-insurance, deductibles, or other limitations may apply.
The questions below are meant to start the conversation with your health plan—there may be other questions you should be asking based on your plan’s benefits.
If there is an annual maximum coverage (such as on wellness or preventive services), we suggest you discuss this issue with your healthcare professional.
GARDASIL® is a vaccine indicated in girls and women 9-26 years of age, for the prevention of infection caused by HPV types 6, 11, 16 and 18, and the following diseases associated with these types: cervical cancer, abnormal and precancerous cervical cells, vulvar and vaginal cancers, abnormal and precancerous vulvar and vaginal cells, and genital warts. GARDASIL® is indicated in boys and men 9-26 years of age for the prevention of infection caused by HPV types 6, 11, 16 and 18, and genital warts caused by HPV types 6 and 11.
GARDASIL® helps prevent these diseases but it does not treat them. And just like all vaccines, GARDASIL® may not fully protect everyone who gets it. GARDASIL® does not protect against all types of HPV. Duration of protection over the long term has not been established. Vaccination with GARDASIL® is not recommended during pregnancy. GARDASIL® may cause side effects and allergic reactions.
Even if you get vaccinated with GARDASIL®, it is still important for women to continue having regular Pap tests.
Only a healthcare professional can decide if GARDASIL® is right for you, your son or your daughter.
Read the Patient Product Information or the Prescribing Information for more information.
This site is intended only for residents of Canada. This Website is for information purposes only.
®Registered Trademark of Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.
Used under license.
©2010 MERCK FROSST CANADA LTD. All rights reserved.
08-11-HPV-10-CDN-84140662-AV